uterine carcinosarcoma
Showing 1 - 17 of 17
Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)
Not yet recruiting
- Ovarian Carcinosarcoma
- Uterine Carcinosarcoma
- Eribulin Mesylate
- Pembrolizumab
- (no location specified)
Jan 31, 2023
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma Trial in United States (Pembrolizumab, Lenvatinib)
Recruiting
- Uterine Carcinosarcoma
- Advanced Uterine Carcinosarcoma
-
Basking Ridge, New Jersey
- +6 more
Apr 27, 2022
Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Uterine Carcinosarcoma
- Rucaparib
- +2 more
-
New York, New York
- +2 more
Apr 4, 2022
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- paclitaxel
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Apr 21, 2021
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Canada, United
Completed
- Endometrial Adenocarcinoma
- +7 more
- Sunitinib Malate
-
Beverly Hills, California
- +28 more
Feb 14, 2020
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in United States (Pazopanib Hydrochloride)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Pazopanib Hydrochloride
-
Aurora, Colorado
- +40 more
Aug 6, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker Analysis)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Ixabepilone
- Laboratory Biomarker Analysis
-
Little Rock, Arkansas
- +77 more
Aug 6, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Laboratory Biomarker Analysis
- Thalidomide
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019
Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma Trial in Canada, United States (saracatinib)
Completed
- Adult Fibrosarcoma
- +14 more
-
Rockledge, Pennsylvania
- +3 more
May 29, 2018
Recurrent Uterine Sarcoma, Stage III Uterine Sarcoma, Stage IV Uterine Sarcoma Trial in Canada, United States (sorafenib
Completed
- Recurrent Uterine Sarcoma
- +3 more
- sorafenib tosylate
-
Duarte, California
- +6 more
Nov 17, 2015
Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Leiomyosarcoma Trial in New York (sorafenib tosylate)
Completed
- Adult Angiosarcoma
- +14 more
- sorafenib tosylate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
May 7, 2014